McIntosh, Lachlan
Jackson, Price
Emmerson, Brittany
Buteau, James P.
Alipour, Ramin
Kong, Grace
Hofman, Michael S.
Article History
Received: 14 August 2023
Accepted: 15 January 2024
First Online: 19 February 2024
Declarations
:
: The VIOLET clinical trial (NCT05521412) was approved from the Peter MacCallum Cancer Centre Human Research Ethics Committee (HREC/88304/PMCC125). This HREC is organised and operates in accordance with the National Health and Medical Research Council’s (NHRMC) National Statement on Ethical Conduct in Human Research (2018), and all subsequent updates, and in accordance with the Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95), the Health Privacy Principles described in the Health Records Act 2001 (Vic) and Section 95A of the Privacy Act 1988 (and subsequent Guidelines). All patients provided written informed consent.
: Not applicable.
: MSH acknowledges research grant support (to institution) from Novartis (including AAA and Endocyte), ANSTO, Bayer, Isotopia, and MIM. Consulting fees for lectures or advisory boards from Astellas and AstraZeneca in the last two years, and Janssen, Merck/MSD, and Mundipharma in the last five years.